Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study

被引：0
|
作者：
Hasan Tahir
Atul Deodhar
Mark Genovese
Tsutomu Takeuchi
Jacob Aelion
Filip Van den Bosch
Sibylle Haemmerle
Hanno B. Richards
机构：
[1] Barts Health NHS Trust,
[2] Oregon Health and Science University,undefined
[3] Stanford University,undefined
[4] Keio University School of Medicine,undefined
[5] West Tennessee Research Institute,undefined
[6] Ghent University Hospital,undefined
[7] Novartis Pharma AG,undefined
来源：
Rheumatology and Therapy | 2017年 / 4卷
关键词：
ACR; Autoimmune; Biologic; Clinical trial; HAQ-DI; IL-17A; Randomized; Rheumatoid arthritis; Secukinumab; vdH-mTSS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 488
页数：13
相关论文
共 50 条
  • [41] Treatment of early rheumatoid arthritis with minocycline or placebo - Results of a randomized, double-blind, placebo-controlled trial
    ODell, JR
    Haire, CE
    Palmer, W
    Drymalski, W
    Wees, S
    Blakely, K
    Churchill, M
    Eckhoff, PJ
    Weaver, A
    Doud, D
    Erikson, N
    Dietz, F
    Olson, R
    Maloley, P
    Klassen, LW
    Moore, GF
    ARTHRITIS AND RHEUMATISM, 1997, 40 (05): : 842 - 848
  • [42] Effect of Certolizumab Pegol On Signs and Symptoms in Patients with Psoriatic Arthritis with and without Prior Anti-TNF Exposure: 24 Week Results of a Phase 3 Double-Blind Randomized Placebo-Controlled Study
    Mease, Philip
    Fleischmann, Roy M.
    Wollenhaupt, Juergen
    Deodhar, Atul A.
    Kielar, Danuta
    Woltering, Franz
    Stach, Christian
    Hoepken, Bengt
    Arledge, Terri
    van der Heijde, Desiree
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1107 - S1107
  • [43] A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis
    Olsen, NJ
    Brooks, RH
    Cush, JJ
    Lipsky, PE
    StClair, EW
    Matteson, EL
    Gold, KN
    Cannon, GW
    Jackson, CG
    McCune, WJ
    Fox, DA
    Teal, G
    Gruber, J
    Espinoza, L
    Caldwell, J
    Weisman, M
    Lee, S
    Abramson, S
    Calabrese, L
    Medsger, T
    Nelson, B
    Lorenz, T
    Strand, V
    ARTHRITIS AND RHEUMATISM, 1996, 39 (07): : 1102 - 1108
  • [44] SECUKINUMAB IMPROVES SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS IN A PHASE 3 RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY USING A SUBCUTANEOUS DOSING REGIMEN (FUTURE 2)
    McInnes, I. B.
    Mease, P.
    Kirkham, B.
    Kavanaugh, A.
    Ritchlin, C.
    Rahman, P.
    Van der Heijde, D.
    Landewe, R.
    Conaghan, P. G.
    Gottlieb, A. B.
    Richards, H.
    Ligozio, G.
    Pricop, L.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 352 - 353
  • [45] APREMILAST FOR ACTIVE ULCERATIVE COLITIS: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Danese, Silvio
    Neurath, Markus
    Kopon, Adam
    Zakko, Salam F.
    Simmons, Timothy C.
    Fogel, Ronald P.
    Maccarone, Judy
    Zhan, Xiaojiang
    Usiskin, Keith
    Chitkara, Denesh
    GASTROENTEROLOGY, 2018, 154 (06) : S167 - S167
  • [46] Randomized, double-blind, placebo-controlled study of efficacy and safety of secukinumab to treat adults with ichthyoses
    Lefferdink, R. L.
    Chima, M.
    Ibler, E.
    Pavel, A. B.
    Kim, H.
    Wu, B.
    Abu-Zayed, H.
    Rangel, S.
    Wu, J.
    Zumpf, K.
    Jackson, K.
    Choate, K.
    Guttman-Yassky, E.
    Paller, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S74 - S74
  • [47] One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
    Genovese, Mark C.
    Durez, Patrick
    Richards, Hanno B.
    Supronik, Jerzy
    Dokoupilova, Eva
    Aelion, Jacob A.
    Lee, Sang-Heon
    Codding, Christine E.
    Kellner, Herbert
    Ikawa, Takashi
    Hugot, Sophie
    Ligozio, Gregory
    Mpofu, Shephard
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (03) : 414 - 421
  • [48] Omega-3 fatty acids as adjuvant therapy in rheumatoid arthritis. A double-blind, randomized, placebo-controlled trial
    Uitz, E.
    Bahadori, B.
    Thonhofer, R.
    Trummer, M.
    Pestemer-Lach, I.
    MacCarty, M.
    Krejs, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 347 - 347
  • [49] Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial
    Ishiguro, Naoki
    Yamamoto, Kazuhiko
    Katayama, Kou
    Kondo, Masakazu
    Sumida, Takayuki
    Mimori, Tsuneyo
    Soen, Satoshi
    Nagai, Kota
    Yamaguchi, Tomonobu
    Hara, Masako
    MODERN RHEUMATOLOGY, 2013, 23 (03) : 430 - 439
  • [50] Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate - A randomized, double-blind, placebo-controlled trial
    Kremer, JM
    Genovese, MC
    Cannon, GW
    Caldwell, JR
    Cush, JJ
    Furst, DE
    Luggen, ME
    Keystone, E
    Weisman, MH
    Bensen, WM
    Kaine, JL
    Ruderman, EM
    Coleman, P
    Curtis, DL
    Kopp, EJ
    Kantor, SM
    Waltuck, J
    Lindsley, HB
    Markenson, JA
    Strand, V
    Crawford, B
    Fernando, I
    Simpson, K
    Bathon, JM
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (09) : 726 - 733
12345